Healthcare Stocks

Opyl (ASX:OPL) collabs with Consentic, launches research screening service

 Opyl (ASX:OPL) collabs with Consentic, launches research screening service

Opyl has collaborated with e-consent platform, Consentic, for tipping up enrolment and recruitment revenues. The company has also launched a new personalised research screening service for its flagship platform.

Read More...
Four ASX healthcare stocks with over 90% gains in past 52 weeks

Four ASX healthcare stocks with over 90% gains in past 52 weeks

NEU, AVR, NTI and CTE are some of the ASX-listed healthcare stocks with over 90% price returns in the last 52 weeks.

Read More...
How are CSL (ASX:CSL) shares performing on YTD basis?

How are CSL (ASX:CSL) shares performing on YTD basis?

Shares of CSL Limited (ASX:CSL) opened in red today despite no price-sensitive news released by the group.

Read More...
ASX-listed healthcare giants in focus today

ASX-listed healthcare giants in focus today

  • September 13, 2022 04:51 PM AEST | Ritwika

The health care sector was the worst performing sector on ASX today. Let us see how the ASX-listed healthcare companies are faring today.

Read More...
Ramsay (ASX:RHC) ends talks on IHH's acquisition proposal

Ramsay (ASX:RHC) ends talks on IHH's acquisition proposal

  • September 09, 2022 11:01 AM AEST | Ritwika

Ramsay concludes all discussion on IHH's proposed acquisition.

Read More...
Healthia (ASX:HLA) calls for a trading halt today, here’s why

Healthia (ASX:HLA) calls for a trading halt today, here’s why

  • September 08, 2022 11:01 AM AEST | Ritwika

Know why Healthia puts its securities under trading halt until Monday.

Read More...
How are CSL (ASX:CSL) shares performing on ASX?

How are CSL (ASX:CSL) shares performing on ASX?

Shares of CSL Limited (ASX:CSL) have dropped by 0.31% per share today despite no price-sensitive news released by the group.

Read More...
AFT Pharma (ASX:AFP) to initiate further studies on Maxigesic IV

AFT Pharma (ASX:AFP) to initiate further studies on Maxigesic IV

  • September 02, 2022 11:59 AM AEST | Ritwika

AFT Pharmaceuticals will conduct additional studies related to Maxigesic IV's packaging before filing for the US FDA registration.

Read More...
Kalkine : Fisher & Paykel (ASX:FPH) to buy land in Auckland for AU$275M

Kalkine : Fisher & Paykel (ASX:FPH) to buy land in Auckland for AU$275M

Fisher & Paykel has signed an agreement to buy a second New Zealand campus.

Read More...
From JTL, to SHG, AYA: How are these healthtech stocks faring on ASX?

From JTL, to SHG, AYA: How are these healthtech stocks faring on ASX?

JTL, OAK, GLH, SHG, and AYA are ASX-listed health tech stocks that were on investor’s radar in August.

Read More...
Mesoblast’s (ASX:MSB) net loss falls to US$91.3M in FY22

Mesoblast’s (ASX:MSB) net loss falls to US$91.3M in FY22

Share price of Mesoblast Limited (ASX:MSB) marked a gain after the company reported a fall in loss after tax.

Read More...

Frequently Asked Questions

Given the fact that healthcare is a necessity, investing in healthcare stocks can be rewarding. However, to make good returns from these stocks, an investor should have sound knowledge about the sector and should be aware of the latest trends in the sector.

The standard checklist that one would run to find a good stock, holds true for screening healthcare stocks too. However, there are few aspects that are important to be considered for healthcare stocks. Well established pharmaceutical stocks with a good history of drug discovery and effective treatments typically have some sort of moat around them, thanks to their scale and financial wherewithal. However, new, and small companies with unique innovations or a strong product pipeline are also worth investigating, as they have a longer runway. Healthcare companies are able to pass on inflation-led input cost pressure, since people usually do not cut back on their healthcare expenses even during an inflationary environment. Companies that are able to maintain good profit margin are seen commanding valuation premiums in the market. Investors can also look for healthcare companies with strong patent portfolio, as patents can provide good price and competition protection for longer periods. Finally, before finalising any share, some of the fundamentals such as return on equity, revenue growth, net margin growth, management capabilities in terms of capital allocation, dividend pay-out should be considered.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK